SVP, FINANCE, CHIEF ACCT OFFCR · Vera Therapeutics, Inc. · Class A Common Stock
Side
M
Value
$20K
Shares
5,000
Price
$3.94
Executed
Sep 11, 2026
Disclosed
Sep 14, 2026
Disclosure timeline3 days from execution to publication · legal deadline 2 business days
Sep 11 executedSep 14, 2026 disclosed
VERA · daily
Yahoo Finance chart API
◉This trade, on the day it was made▼Disclosure●Material company filing◯Other disclosed buy◯Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Option exercise — administrative, little informational value
Relative size+5 / 25
$20K reported value · 6.6% of prior position
Filing timing0 / 15
Disclosed 1 business day after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Young Joseph R filed this Form 4 reporting a option exercise of VERA on Sep 11, 2026. It became public on Sep 14, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
SVP, FINANCE, CHIEF ACCT OFFCR
Young Joseph Rcik:0001861684
Issuer
Vera Therapeutics, Inc.cik:0001831828
Revision history · 0
No field has changed since this record was first ingested.
